retatrutide glp-1 gip glucagon triple agonist vs Tirzepatide Compared Retatrutide 10mg/vial - Koru iPharma

Eli Lilly received FDA approval for its tirzepatide-based GLP-1 products, Mounjaro for diabetes and Zepbound for weight loss in May 2022 and November 2023, respectively

Tirzepatide for the treatment of obstructive sleep apnea: rationale, design, and sample baseline characteristics of the SURMOUNT -OSA phase 3 trial

Our team provides personalized treatment plans that may include GLP-1 for weight management, FibroScan for liver assessment, or UltraSlim for body contouring, depending on your needs

JAMA 334 , 12311234 (2025)

But stopping cold turkey typically produces appetite rebounds that are far harder to manage

Red Flags Nausea on GLP-1 Therapy: When It Is a Dose Issue and When It Needs Attention Nausea is one of the most common side effects patients ask about during GLP-1 therapy